Prime Health

Prime Health keeps pricing simple with flat monthly fees of $299 for compounded semaglutide and $399 for compounded tirzepatide, regardless of dose escalation. Each 28-day shipment bundles the clinician consult, required labs, needles, and sharps disposal supplies, so patients are not surprised by add-on fees. The program is cash-pay only and auto-bills every 28 days, which rewards higher-dose patients but requires close budgeting. A 10 percent weight-loss guarantee after 16 weeks, with refunds for the first four months if criteria are met, adds a consumer safeguard uncommon in this category. Lack of insurance billing and no refunds once a prescription is processed remain the main cost tradeoffs.

Clinical teams review medical histories within roughly 24 hours and titrate doses based on vitals, keeping oversight aligned with evidence-based GLP-1 protocols. Every patient-facing page reiterates that medications are compounded rather than FDA-approved and outlines contraindications, administration steps, and storage requirements. Partner pharmacies handle fulfillment, which can introduce subtle packaging differences, but instructions and vial volumes stay consistent across the network. Detailed injection guides, safety disclosures, and refrigeration reminders help patients dose correctly at home. Overall, the program balances speed with transparent clinical guardrails.

Enrollment starts with an online intake, recent labs or an at-home kit, and payment, after which a clinician review is completed in about 24 hours. Once approved, medications typically ship within five to seven days, and coverage spans almost every state except Louisiana, keeping access broad for most cash-pay patients. The portal flags the 10 percent weight-loss guarantee requirements up front so members can document weight trends from day one. Auto-billing every 28 days reduces friction, but patients should time cancellations before the next processing date because charges are non-refundable once prescriptions are written. Compared with peers, Prime streamlines the path from questionnaire to first dose.

Prime focuses on two compounded GLP-1 options, semaglutide and tirzepatide, both delivered as weekly injections with titration directed by the clinical team. Starting doses mirror clinical guidelines at 0.25 mg for semaglutide and 2.5 mg for tirzepatide, with adjustments made remotely as tolerability and outcomes evolve. Each monthly shipment contains a four-dose vial, needles, and alcohol swabs, so patients do not have to source supplies separately. There are no brand-name or oral GLP-1 alternatives, which keeps the program tight but limits choice for patients seeking non-compounded or pill-based therapies. For those committed to compounded injectables, the offer covers the core needs without upsells.

After approval, Prime routes prescriptions through partner compounding pharmacies that mix, package, and ship the medication on a 28-day cadence. Typical delivery windows are five to seven days, and shipments arrive cold-packed with clear storage instructions to maintain potency. Because multiple pharmacies are used, vial shape or labeling can vary, but fill volumes are standardized and replacements are issued if there is a break in the cold chain. Tracking information comes from the dispensing pharmacy, and Prime's help center explains what to expect in each box and how to confirm dosage accuracy on arrival. Reliability remains solid, though public materials could provide clearer day-by-day timelines.

Members can message clinicians seven days a week for dose adjustments, side effect management, or guarantee documentation, which is critical for a self-injection program. Phone support runs during weekday business hours, so urgent needs outside that window rely on asynchronous messaging. The resource library includes injection demos, refrigeration guidance, and FAQs covering the 10 percent guarantee and cancellation process, helping patients self-serve. Prime also outlines how to escalate concerns about shipment temperature or pharmacy errors, something many competitors gloss over. The main gap is the absence of live chat or round-the-clock phone triage.

Testing the intake flow shows a friction-light experience: the questionnaire, health history upload, and payment happen in a single session with clear status indicators. With only compounded semaglutide and tirzepatide on offer, navigation stays focused on dose titration, delivery timing, and side effect guidance rather than upsell paths. The help center is referenced throughout the workflow, so injection instructions and guarantee rules surface when patients are making decisions. The tradeoff is a minimalist toolset with no native app, progress tracker, or insurance coordination, which may underwhelm patients looking for a more hands-on coaching platform. For speed and clarity, the experience lands as clean and utilitarian.